Table 1.
Baseline clinical characteristics and laboratory findings of patients.
| Age (yr) | 55.3 ± 17.8 |
| Male (%) | 163 (56.8) |
| Body weight (kg) | 61.0 ± 11.8 |
| Height (cm) | 162. 9 ± 10.1 |
| Systolic pressure (mmHg) | 119.2 ± 16.2 |
| Diastolic pressure (mmHg) | 75.2 ± 11.0 |
| Drug duration (days) | 8.8 ± 5.6 |
| Total drug doses (mg) | 12527.7 ± 9096.1 |
| Hydration (%) | 149 (51.9%) |
| Hydration amount (ml/hr) | 63.1 ± 31.8 |
| Kinds of infusion fluid | |
| 0.45% saline | 36 (22.2%) |
| 0.90% saline | 113 (77.8%) |
| Underlying disease | |
| DM | 44 (15.3%) |
| Hypertension | 66 (23%) |
| CKD | 12 (4.2%) |
| Cancer | 105 (36.6%) |
| Concomitant drugs | |
| Radiocontrast dye | 61 (21.3%) |
| Ceftriaxone | 44 (15.3%) |
| ARB or ACEi | 13 (4.5%) |
| Vancomycin | 16 (5.6%) |
| NSAIDs | 24 (8.4%) |
| Mannitol | 8 (2.8%) |
| Diuretics | 9 (3.1%) |
| Laboratory findings | |
| WBC (×103/uL) | 7.8 ± 3.4 |
| Hemoglobin (g/dL) | 12.0 ± 2.2 |
| Platelet (×103 /mm3) | 165.3 ± 54.5 |
| Sodium (mmol/L) | 138.6 ± 7.8 |
| Potassium (mmol/L) | 4.6 ± 1.4 |
| Albumin (g/dL) | 3.6 ± 0.7 |
| BUN (mg/dL) | 16.8 ± 11.6 |
| Cr (mg/dL) | 0.9 ± 0.7 |
| CRP (mg/L) | 24.2 ± 7.4 |
ARB: Angiotensin Receptor Blocker; ACEi: Angiotensin Converting Enzyme Inhibitor; WBC: White Blood Cell; NSAIDs: Non-Steroidal Anti-inflammatory Drugs; CRP: C-reactive Protein; BUN: Blood Urea Nitrogen; Cr: Creatinine; DM: Diabetes Mellitus; CKD: Chronic Kidney Disease.